FB2026_02 , released June 18, 2026
Human Disease Model Report: hyperoxaluria, primary, type 1
Open Close
General Information
Name
hyperoxaluria, primary, type 1
FlyBase ID
FBhh0000971
Disease Ontology Term
Parent Disease
Overview

This report describes primary hyperoxaluria, type 1 (HP1 pr PH1), which is a subtype of primary hyperoxaluria; HP1 exhibits autosomal recessive inheritance. The human gene implicated in this disease is AGXT, a liver peroxisomal enzyme that catalyzes the conversion of glyoxylate to glycine. There is a single orthologous gene in Drosophila, Agxt, for which RNAi-targeting constructs have been generated.

The human AGXT gene has not been introduced into flies.

The Malpighian tubules of wild-type animals and animals in which ubiquitous knockdown of Dmel\Agxt was effected by RNAi were examined and compared for crystal formation; energy dispersive X-ray spectroscopy (EDS) was used to identify the chemical composition of detected crystals. On a normal diet, the Agxt-knockdown, but not the wild-type, animals developed calcium oxalate crystals; on a diet supplemented with sodium oxalate, both groups developed crystals. This system has been used to assess the efficacy of therapeutic options.

[updated Feb. 2019 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: hyperoxaluria, primary
Symptoms and phenotype

Primary hyperoxaluria is characterized by an accumulation of nonsoluble calcium oxalate in various bodily tissues, especially the kidney, resulting in renal failure. [from MIM:259900; 2019.02.14]

Specific Disease Summary: hyperoxaluria, primary, type 1
OMIM report

[HYPEROXALURIA, PRIMARY, TYPE I; HP1](https://omim.org/entry/259900)

Human gene(s) implicated

[ALANINE-GLYOXYLATE AMINOTRANSFERASE; AGXT](https://omim.org/entry/604285)

Symptoms and phenotype
Genetics

Type I primary hyperoxaluria (HP1) is caused by homozygous or compound heterozygous mutation in the gene encoding alanine-glyoxylate aminotransferase (AGXT). [from MIM:259900; 2019.02.14]

Cellular phenotype and pathology
Molecular information

The AGXT gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. [Gene Cards, AGXT; 2019.02.14]

Primary hyperoxaluria type 1 (PH1) is caused by a deficiency of the liver peroxisomal enzyme alanine:glyoxylate-aminotransferase (AGT), which catalyzes the conversion of glyoxylate to glycine. When AGT activity is absent, glyoxylate is converted to oxalate, which forms insoluble calcium oxalate crystals that accumulate in the kidney and other organs. [Gene Reviews, Primary Hyperoxaluria Type 1; 2019.02.14]

Affected individuals have decreased or absent AGXT activity and a failure to transaminate glyoxylate, which causes the accumulated glyoxylate to be oxidized to oxalate. [from MIM:259900; 2019.02.14]

External links
Disease synonyms
alanine-glyoxylate aminotransferase deficiency
glycolic aciduria
hepatic agt deficiency
HP1
oxalosis I
peroxisomal alanine:glyoxylate aminotransferase deficiency
Search term: nephrolithiasis
Search term: nephrolithiasis, calcium oxalate
serine:pyruvate aminotransferase deficiency
Ortholog Information
Human gene(s) in FlyBase
    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    One to one: 1 human to 1 Drosophila.

    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (1)
      Gene Snapshot
      Alanine-glyoxylate aminotransferase (Agxt) encodes an enzyme involved in glyoxylate catabolism. [Date last reviewed: 2019-09-19]
      Cellular component (GO)
      Gene Groups / Pathways
      Comments on ortholog(s)

      High-scoring ortholog of human AGXT (1 Drosophila to 1 human). Dmel\Agxt shares 46% identity and 63% similarity with the human gene.

      Orthologs and Alignments from DRSC
      DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (0 groups)
        Alleles Reported to Model Human Disease (Disease Ontology) (1 alleles)
        Models Based on Experimental Evidence ( 1 )
        Allele
        Disease
        Evidence
        References
        Modifiers Based on Experimental Evidence ( 0 )
        Allele
        Disease
        Interaction
        References
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        References (5)